Effect of epinephrine on muscle glycogenolysis and insulin-stimulated muscle glycogen synthesis in humans
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
To examine the effects of a physiological increase in plasma epinephrine concentration (∼800 pg/ml) on muscle glycogenolysis and insulin-stimulated glycogenesis, we infused epinephrine [1.2 μg ⋅ (m 2 body surface)−1⋅ min−1] for 2 h and monitored muscle glycogen and glucose 6-phosphate (G-6- P) concentrations with 13 C/31 P nuclear magnetic resonance (NMR) spectroscopy. Epinephrine caused an increase in plasma glucose (Δ ∼50 mg/dl), lactate (Δ ∼1.4 mM), free fatty acids (Δ ∼1,200 μM at peak), and whole body glucose oxidation (Δ ∼0.85 mg ⋅ kg−1⋅ min−1) compared with levels in a group of control subjects ( n = 4) in the presence of slight hyperinsulinemia (∼13 μU/ml, n = 8) or basal insulin (∼7 μU/ml, n = 7). However, epinephrine did not induce any detectable changes in glycogen or G-6- P concentrations, whereas muscle inorganic phosphate (P i) decreased by 35%. Epinephrine infusion during a euglycemic-hyperinsulinemic clamp ( n = 8) caused a 45% decrease in the glucose infusion rate that could be mostly attributed to a 73% decrease in muscle glycogen synthesis rate. After an initial increase to ∼160% of basal values, G-6- Plevels decreased by ∼30% with initiation of the epinephrine infusion. We conclude that a physiological increase in plasma epinephrine concentration 1) has a negligible effect on muscle glycogenolysis at rest, 2) decreases muscle P i, which may maintain phosphorylase activity at a low level, and 3) causes a major impairment in insulin-stimulated muscle glycogen synthesis, possibly due to inhibition of glucose transport-phosphorylation activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanism of free fatty acid-induced insulin resistance in humans.
Roden, M., Price, T. B., Perseghin, G., Petersen, K. F., Rothman, D. L., Cline, G. W., & Shulman, G. I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118742 · Cited by 1,539 · cited 1×
“(34), suggests that either reduced activity of muscle glucose transporter or hexokinase activity is responsible for the impaired muscle glycogen synthesis.”
BackgroundSelf-citationShulman, G. I., Rothman, D. L., Jue, T., Stein, P., DeFronzo, R. A., & Shulman, R. G. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001253220403 · Cited by 1,248 · cited 1×
“Continuous indirect calorimetry was performed to determine rates of total body glucose and lipid oxidation at baseline and at 100–120 and 220–240 min into the study as previously described (38).”
MethodSelf-citationEpinephrine-induced insulin resistance in man
Deibert, D. C., & Defronzo, R. A. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109718 · Cited by 557 · cited 2×
“Finally, it is well known that an increase in plasma epinephrine concentration causes insulin resistance (13, 37), although the mechanism for this effect remains unclear.”
BackgroundGlucagon and plasma catecholamine responses to graded and prolonged exercise in man
Galbo, H., Holst, J. J., & Christensen, N. J. (1975) · Journal of Applied Physiology · doi:10.1152/jappl.1975.38.1.70 · Cited by 406
A Receptor Mechanism for the Inhibition Of Insulin Release by Epinephrine in Man*
Porte, D. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105514 · Cited by 398 · cited 1×
“Epinephrine is known to inhibit insulin secretion (28) but will also cause hyperglycemia, which can secondarily increase insulin secretion (15).”
BackgroundGarber, A. J., Cryer, P. E., Santiago, J. V., Haymond, M. W., Pagliara, A. S., & Kipnis, D. M. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108460 · Cited by 351
Rothman, D. L., Magnusson, I., Cline, G., Gerard, D., Kahn, C. R., Shulman, R. G., & Shulman, G. I. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.983 · Cited by 325 · cited 3×
“13C spectra were processed by methods that have previously been described (29, 35).”
MethodSelf-citationSynergistic Interactions of Physiologic Increments of Glucagon, Epinephrine, and Cortisol in the Dog
Eigler, N., Saccà, L., & Sherwin, R. S. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109264 · Cited by 260 · cited 1×
“Epinephrine is known to inhibit insulin secretion (28) but will also cause hyperglycemia, which can secondarily increase insulin secretion (15).”
BackgroundHuman muscle glycogen resynthesis after exercise: insulin-dependent and -independent phases
Price, T. B., Rothman, D. L., Taylor, R., Avison, M. J., Shulman, G. I., & Shulman, R. G. (1994) · Journal of Applied Physiology · doi:10.1152/jappl.1994.76.1.104 · Cited by 168
Self-citationGlucose metabolism and plasma insulin level during epinephrine infusion in the dog
Altszuler, N., Steele, R., Rathgeb, I., & De Bodo, R. (1967) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1967.212.3.677 · Cited by 78
Cited by
New insights into sympathetic regulation of glucose and fat metabolism
Nonogaki, K. (2000) · Diabetologia · doi:10.1007/s001250051341 · Cited by 575
The Role of Skeletal Muscle Glycogen Breakdown for Regulation of Insulin Sensitivity by Exercise
Jensen, J., Rustad, P. I., Kolnes, A. J., & Lai, Y.-C. (2011) · Frontiers in Physiology · doi:10.3389/fphys.2011.00112 · Cited by 412
“Indeed, not all studies find that adrenaline infusion reduces glycogen content in humans (Laurent et al., 1998), but it has consistently been reported release of lactate from muscles during adrenaline infusion (Simonsen et al., 1992; Qvisth et al., 2007; Gjedsted et al., 2011).”
BackgroundMechanism of Amino Acid-Induced Skeletal Muscle Insulin Resistance in Humans
Krebs, M., Krssak, M., Bernroider, E., Anderwald, C., Brehm, A., Meyerspeer, M., Nowotny, P., Roth, E., Waldhäusl, W., & Roden, M. (2002) · Diabetes · doi:10.2337/diabetes.51.3.599 · Cited by 392
Tremblay, F., Krebs, M., Dombrowski, L., Brehm, A., Bernroider, E., Roth, E., Nowotny, P., Waldhäusl, W., Marette, A., & Roden, M. (2005) · Diabetes · doi:10.2337/diabetes.54.9.2674 · Cited by 370
The effect of caffeine on glucose kinetics in humans - influence of adrenaline
Battram, D. S., Graham, T. E., Richter, E. A., & Dela, F. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.097444 · Cited by 44
“Adrenaline in high concentrations (3–4 nm) is known to inhibit insulin-mediated, whole-body glucose disposal by 40–50% (Deibert & DeFronzo, 1980; Bessey et al. 1983; Baron et al. 1987; Laurent et al. 1998).”
Background
Metadata
- Authors
- Laurent, D., Petersen, K. F., Russell, R. R., Cline, G. W., & Shulman, G. I.
- Venue
- American Journal of Physiology-Endocrinology and Metabolism
- Publisher
- American Physiological Society
- Published
- 1998-01-01
- Volume
- 274
- Issue
- 1
- Pages
- E130-E138
- ISSN
- 0193-1849 (ISSN-L)
- 1522-1555
- OpenAlex
- W2168317493
- Cited by
- 48
- References
- 10
- FWCI
- 0.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of epinephrine on muscle glycogenolysis and insulin-stimulated muscle glycogen synthesis in humans. https://app.cochat.ai/papers/10.1152/ajpendo.1998.274.1.e130
- The paper
- Laurent, D., Petersen, K. F., Russell, R. R., Cline, G. W., & Shulman, G. I. (1998). Effect of epinephrine on muscle glycogenolysis and insulin-stimulated muscle glycogen synthesis in humans. American Journal of Physiology-Endocrinology and Metabolism. https://doi.org/10.1152/ajpendo.1998.274.1.e130
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.